Posters

Brightocular cosmetic iris implants: perils and progress

Poster Details

First Author: W.Kheir LEBANON

Co Author(s):    A. Mansour   I. Ahmed   B. Eadie   E. Chelala   J. Saade   S. Slade

Abstract Details

Purpose:

NewColorIris cosmetic iris implants have a record of high ocular morbidity and are no longer in use. Newer generation of iris implants, BrightOcular, have patented posterior grooves in order to decrease iris touch and facilitate aqueous flow around the implant. However, little is known about their safety despite their implantations in 10 countries.

Setting:

American University of Beirut, University of Toronto and Hotel Dieu de France (Beirut)

Methods:

Collaborative case series of patients who had bilateral implantation of cosmetic iris implants solely for cosmetic reasons.

Results:

12 cases were collected being distributed as Caucasian (10) and Asian (2), women (11) and man (1), and with a mean age of 32 years. Ocular manifestations were present in 11 subjects and included anterior uveitis (10 of 12; 83.3%), glaucoma (7 of 12; 58.3%) and corneal decompensation (6 of 12; 50%). Visual acuity was normal in 7, decreased in 5 with 2 having visual recovery following explantation of the implant. Glaucoma could not be controlled medically in 2 patients.

Conclusions:

Cosmetic iris implants carry the risk of ocular damage when implanted in the anterior chamber of normal phakic eyes. FINANCIAL DISCLOUSRE: NONE